BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16680034)

  • 41. Longitudinal differences in familial combined hyperlipidemia quantitative trait loci.
    Pollex RL; Hegele RA
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):e120. PubMed ID: 16709948
    [No Abstract]   [Full Text] [Related]  

  • 42. Longitudinal differences in familial combined hyperlipidemia quantitative trait loci.
    Brouwers MC; Kono N; van Greevenbroek MM; van der Kallen CJ; Lusis AJ; de Bruin TW; Cantor RM
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):e118-9. PubMed ID: 16709947
    [No Abstract]   [Full Text] [Related]  

  • 43. Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting.
    Civeira F; Jarauta E; Cenarro A; García-Otín AL; Tejedor D; Zambón D; Mallen M; Ros E; Pocoví M
    J Am Coll Cardiol; 2008 Nov; 52(19):1546-53. PubMed ID: 19007590
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.
    Skoumas I; Masoura C; Pitsavos C; Tousoulis D; Papadimitriou L; Aznaouridis K; Chrysohoou C; Giotsas N; Toutouza M; Tentolouris C; Antoniades C; Stefanadis C
    Int J Cardiol; 2007 Oct; 121(2):178-83. PubMed ID: 17188767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Familial combined hyperlipidaemia: how can genetic disorders be common, complex and comprehensible?
    Sniderman A; Bailey SD; Engert JC
    Clin Sci (Lond); 2007 Nov; 113(9):365-7. PubMed ID: 17608621
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Identifying different susceptibility loci associated with early onset diabetes and cardiovascular disease in Mexican families].
    Canizales-Quinteros S; Huertas-Vázquez A; Riba-Ramírez L; Monroy-Guzmán A; Domínguez-López A; Romero-Hidalgo S; Aguilar-Salinas C; Rodríguez-Torres M; Ramírez-Jiménez S; Tusié-Luna MT
    Gac Med Mex; 2005; 141(2):115-22. PubMed ID: 15892459
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathway analysis detect potential mechanism for familial combined hyperlipidemia.
    Wang YL; Xue F; Liu LZ; He ZH
    Eur Rev Med Pharmacol Sci; 2013 Jul; 17(14):1909-15. PubMed ID: 23877856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Objective prioritization of positional candidate genes at a quantitative trait locus for pre-eclampsia on 2q22.
    Moses EK; Fitzpatrick E; Freed KA; Dyer TD; Forrest S; Elliott K; Johnson MP; Blangero J; Brennecke SP
    Mol Hum Reprod; 2006 Aug; 12(8):505-12. PubMed ID: 16809377
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Upstream transcription factor 1 (USF1) in risk of type 2 diabetes: association study in 2000 Dutch Caucasians.
    Meex SJ; van Vliet-Ostaptchouk JV; van der Kallen CJ; van Greevenbroek MM; Schalkwijk CG; Feskens EJ; Blaak EE; Wijmenga C; Hofker MH; Stehouwer CD; de Bruin TW
    Mol Genet Metab; 2008 Jul; 94(3):352-5. PubMed ID: 18445538
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 British families with familial combined hyperlipidemia.
    Cullen P; Farren B; Scott J; Farrall M
    Arterioscler Thromb; 1994 Aug; 14(8):1233-49. PubMed ID: 8049184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Apolipoprotein genes].
    Ishibashi S
    Nihon Rinsho; 1997 Oct; 55 Suppl():490-7. PubMed ID: 9392155
    [No Abstract]   [Full Text] [Related]  

  • 52. Body mass index is associated with USF1 haplotype in Korean premenopausal women.
    Lee SK; Kim HJ; Kim BJ; Jo YS; Park KS; Baik HW; Hyun SH; Lee JC; Kim SA
    J Korean Med Sci; 2008 Feb; 23(1):83-8. PubMed ID: 18303204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of genetic heterogeneity of hypertriglyceridemia upon the risk of coronary heart disease.
    Vaverková H; Weinbergová O; Horcicka V; Kubasta M; Vrublovský P
    Acta Univ Palacki Olomuc Fac Med; 1987; 117():167-73. PubMed ID: 2977686
    [No Abstract]   [Full Text] [Related]  

  • 54. [Familial combined hyperlipidemia].
    Martin G; Shviro I; Staels B; Auwerx J
    Ann Endocrinol (Paris); 1997; 58(4):283-6. PubMed ID: 9436474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is familial combined hyperlipidaemia a genetic disorder of adipose tissue?
    Arner P
    Curr Opin Lipidol; 1997 Apr; 8(2):89-94. PubMed ID: 9183546
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Familial combined hyperlipidemia. Part II. Clinical picture.
    Vaverková H; Weinbergová O; Horcicka V; Kubasta M; Vrublovský P
    Acta Univ Palacki Olomuc Fac Med; 1986; 114():243-59. PubMed ID: 2946184
    [No Abstract]   [Full Text] [Related]  

  • 57. Association analysis of allelic variants of USF1 in coronary atherosclerosis.
    Kristiansson K; Ilveskoski E; Lehtimäki T; Peltonen L; Perola M; Karhunen PJ
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):983-9. PubMed ID: 18276913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Genetics of hereditary dyslipidemia now becoming clear].
    Pajukanta P; Palotie L
    Duodecim; 1998; 114(15):1447, 1449. PubMed ID: 11552231
    [No Abstract]   [Full Text] [Related]  

  • 59. [Familial combined hyperlipidemia].
    Kastelein JJ; ten Cate JW
    Ned Tijdschr Geneeskd; 1997 Apr; 141(15):747-8. PubMed ID: 9213793
    [No Abstract]   [Full Text] [Related]  

  • 60. [Familial combined hyperlipidemia].
    Bredie SJ; Stalenhoef AF
    Ned Tijdschr Geneeskd; 1996 Dec; 140(50):2528. PubMed ID: 9005339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.